These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 2406875)

  • 41. Synergism and antagonism in double beta-lactam antibiotic combinations.
    Gutmann L; Williamson R; Kitzis MD; Acar JF
    Am J Med; 1986 May; 80(5C):21-9. PubMed ID: 3487247
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of beta-lactamase-mediated antimicrobial resistance: the role of beta-lactamase inhibitors.
    Maddux MS
    Pharmacotherapy; 1991; 11(2 ( Pt 2)):40S-50S. PubMed ID: 2041831
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mechanisms and clinical significance of resistance to new beta-lactam antibiotics.
    Livermore DM; Wood MJ
    Br J Hosp Med; 1990 Oct; 44(4):252-8, 261-3. PubMed ID: 2249100
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Emergence of resistance to beta-lactam antibiotics in Pseudomonas aeruginosa during treatment with new beta-lactams.
    Lerner SA; Quinn JP
    Chemioterapia; 1985 Feb; 4(1):95-101. PubMed ID: 3921267
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Penicillin binding proteins and resistance to beta-lactam antibiotics in Staphylococcus aureus.
    Fontana R; Rossi L; Rong YC; Tonin E
    Chemioterapia; 1985 Feb; 4(1):53-5. PubMed ID: 3986945
    [No Abstract]   [Full Text] [Related]  

  • 46. Review of the in vitro spectrum of activity of imipenem.
    Jones RN
    Am J Med; 1985 Jun; 78(6A):22-32. PubMed ID: 3890537
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantitative relationship between sensitivity to beta-lactam antibiotics and beta-lactamase production in gram-negative bacteria--II. Non-steady-state treatment and progress curves.
    Frère JM; Joris B; Crine M; Martin HH
    Biochem Pharmacol; 1989 May; 38(9):1427-33. PubMed ID: 2655602
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Contribution of the MexAB-OprM multidrug efflux system to the beta-lactam resistance of penicillin-binding protein and beta-lactamase-derepressed mutants of Pseudomonas aeruginosa.
    Srikumar R; Tsang E; Poole K
    J Antimicrob Chemother; 1999 Oct; 44(4):537-40. PubMed ID: 10588316
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibacterial properties of the bicyclic pyrazolidinones.
    Allen NE; Hobbs JN; Preston DA; Turner JR; Wu CY
    J Antibiot (Tokyo); 1990 Jan; 43(1):92-9. PubMed ID: 1689710
    [TBL] [Abstract][Full Text] [Related]  

  • 50. beta-lactam resistance in Streptococcus pneumoniae: penicillin-binding proteins and non-penicillin-binding proteins.
    Hakenbeck R; Grebe T; Zähner D; Stock JB
    Mol Microbiol; 1999 Aug; 33(4):673-8. PubMed ID: 10447877
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanisms responsible for reduced susceptibility to imipenem in Bacteroides fragilis.
    Edwards R; Greenwood D
    J Antimicrob Chemother; 1996 Dec; 38(6):941-51. PubMed ID: 9023641
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular basis of the non-beta-lactamase-mediated resistance to beta-lactam antibiotics in strains of Haemophilus influenzae isolated in Canada.
    Clairoux N; Picard M; Brochu A; Rousseau N; Gourde P; Beauchamp D; Parr TR; Bergeron MG; Malouin F
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1504-13. PubMed ID: 1510447
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [BLNAR (beta-lactamase-nonproducing ampicillin-resistant Haemophilus influenzae)].
    Ubukata K
    Nihon Rinsho; 2003 Mar; 61 Suppl 3():176-81. PubMed ID: 12717968
    [No Abstract]   [Full Text] [Related]  

  • 54. Resistance to beta-lactam antibiotics and its mediation by the sensor domain of the transmembrane BlaR signaling pathway in Staphylococcus aureus.
    Golemi-Kotra D; Cha JY; Meroueh SO; Vakulenko SB; Mobashery S
    J Biol Chem; 2003 May; 278(20):18419-25. PubMed ID: 12591921
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Resistance to beta-lactam antibiotics in Streptococcus faecium.
    Eliopoulos GM; Wennersten C; Moellering RC
    Antimicrob Agents Chemother; 1982 Aug; 22(2):295-301. PubMed ID: 6927638
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of resistance to beta-lactam antibiotics with special reference to third-generation cephalosporins.
    Collatz E; Gutmann L; Williamson R; Acar JF
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():13-21. PubMed ID: 6334073
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mode of action of beta-lactam antibiotics.
    Tipper DJ
    Pharmacol Ther; 1985; 27(1):1-35. PubMed ID: 3889939
    [No Abstract]   [Full Text] [Related]  

  • 58. SQ 26,180, a novel monobactam. I Taxonomy, fermentation and biological properties.
    Wells JS; Trejo WH; Principe PA; Bush K; Georgopapadakou N; Bonner DP; Sykes RB
    J Antibiot (Tokyo); 1982 Feb; 35(2):184-8. PubMed ID: 6978877
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microbiology: proteins that bind the beta-lactam antibiotics.
    Coulson AF
    Nature; 1984 Jun 21-27; 309(5970):668. PubMed ID: 6374473
    [No Abstract]   [Full Text] [Related]  

  • 60. Lipopolysaccharide alterations responsible for combined quinolone and beta-lactam resistance in Pseudomonas aeruginosa.
    Leying HJ; Büscher KH; Cullmann W; Then RL
    Chemotherapy; 1992; 38(2):82-91. PubMed ID: 1591950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.